GRACEcast Lung Cancer Audio
136 episodes - English - Latest episode: over 10 years ago - ★★★★★ - 1 ratingOncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
Molecular Markers in Lung Cancer Pt 1: Dr. Charles Rudin on The Lung Cancer Mutation Consortium (audio)
April 06, 2012 23:58 - 17 minutes - 16.1 MBDr. Charles Rudin from Johns Hopkins covers the work from the Lung Cancer Mutation Consortium that identified a wide range of molecular markers in patients with lung adenocarcinoma.
Lung Cancer Highlights in 2011: Question and Answer Session with Dr. Jared Weiss (audio)
March 28, 2012 22:40 - 18 minutes - 16.7 MBQ and A session with Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, about highlights in lung cancer in 2011.
Lung Cancer Highlights in 2011: Lung Cancer screening and Treating Advanced Lung Cancer in the Elderly (audio)
March 21, 2012 15:00 - 13 minutes - 12.8 MBDr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, here describing evidence supporting lung cancer screening by chest CT, as well as evidence on how best to treat elderly patients with advanced lung cancer.
Lung Cancer Highlights in 2011: ALK and New Molecular Targets (audio)
March 18, 2012 15:00 - 8 minutes - 7.69 MBDr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, with this podcast focusing on ALK rearrangements and new molecular targets in lung cancer.
GRACEcast Feeds Moving (audio)
March 14, 2012 21:58 - 1 minute - 1.51 MBThe GRACEcast feeds on iTunes are moving!
Lung Cancer Highlights in 2011: The EGFR Axis (audio)
March 14, 2012 01:26 - 11 minutes - 10.3 MBDr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, focusing here on treatments focusing on the EGFR axis.
Tips and Tools for Smoking Cessation, by Dr. Mark Millard (audio)
March 10, 2012 09:39 - 27 minutes - 25.5 MBDr. Mark Millard, Pulmonologist at Baylor University, describes how to approach smoking cessation and a range of tools for helping smokers who are motivated to quit.
A History of Tobacco and the Rise of Lung Cancer, by Dr. Mark Millard (audio)
January 02, 2012 03:39 - 20 minutes - 18.7 MBDr. Mark Millard, Pulmonologist at Baylor University, reviews the history of tobacco in North America, early research leading to the association of tobacco with lung cancer, and a discussion of how lung cancer prevalence follows patterns of tobacco use.
Challenging Cases in Lung Cancer: Acquired Resistance to EGFR TKI Therapy in a Patient with an Activating EGFR Mutation (audio)
December 16, 2011 18:21 - 28 minutes - 26 MBCase-based discussion with multiple lung cancer experts on optimal treatment of a patient with advanced lung adenocarcinoma, EGFR mutation, & now acquired resistance to EGFR TKI after very good prior response.
Detection and Work-Up of Lung Nodules, by David Yankelevitz (audio)
December 04, 2011 06:49 - 33 minutes - 30.5 MBDr. David Yankelevitz, Professor of Radiology at Mount Sinai Medical Center in New York City, reviews technical advances in CT screening for lung nodules, features suggesting whether a nodule is benign or malignant, and the CT-guided biopsy procedure.
Q and A Session with Drs. Ben Solomon and Ross Camidge on ALK Inhibition for Advanced NSCLC (audio)
November 21, 2011 16:00 - 12 minutes - 11.7 MBDrs. Ben Solomon (Peter MacCallum Cancer Center in Melbourne) and Ross Camidge (Univ. of Colorado) answer Qs on ALK rearrangements and crizotinib (XALKORI) for advanced non-small cell lung cancer (NSCLC).
ALK Inhibition: Who to Screen, and Additional Options for ALK-Positive Patients, by Dr. Ross Camidge (audio)
November 12, 2011 01:30 - 26 minutes - 24.7 MBDr. Ross Camidge reviews considerations of who to screen for an ALK rearrangement and additional treatment alternatives for patients with ALK-positive advanced non-small cell lung cancer.
ALK Inhibition: Science and Early Clinical Experience, by Dr. Ben Solomon (audio)
October 31, 2011 06:49 - 17 minutes - 16.1 MBDr. Ben Solomon of Peter MacCallum Cancer Centre in Melbourne Australia reviews ALK Inhibition from mechanism of action to activity and side effect profile of crizotinib, newly approved for patients with ALK-positive advanced non-small cell lung cancer.
Q and A Session with Dr. Rogerio Lilenbaum, on Managing Lung Cancer in Elderly Patients (audio)
October 10, 2011 23:22 - 7 minutes - 7.28 MBDr. Rogerio Lilenbaum, lung cancer expert, medical oncologist, & Chairman of Cleveland Clinic Florida, answers questions on special management considerations for elderly and frail patients with lung cancer.
Challenges and Special Considerations in Treating Elderly and Poor Risk Patients with Lung Cancer, with Dr. Rogerio Lilenbaum (audio)
October 02, 2011 08:18 - 41 minutes - 37.9 MBDr. Rogerio Lilenbaum, medical oncologist and Chair of Heme/Onc at Cleveland Clinic in Weston, FL, reviews evidence on how age and other medical problems should be incorporated into management of lung cancer.
Q and A Session with Dr. Mario Lacouture, on Skin, Hair, and Nail Care Issues in Cancer Patients (audio)
September 21, 2011 02:17 - 18 minutes - 16.8 MBDr. Mario Lacouture, expert dermatologist at Memorial Sloan-Kettering Cancer Center in NYC, answers questions on management of side effects related to skin, hair, and nails for patients on cancer treatments that cause dermatologic complications.
Challenging Cases in Lung Cancer: Unresectable Locally Advanced NSCLC (audio)
August 24, 2011 15:00 - 13 minutes - 12.7 MBCase-based discussion with multiple lung cancer experts on the controversial question of whether to recommend consolidation chemotherapy after concurrent chemotherapy and radiation for locally advanced NSCLC.
ASCO 2011 Highlights: Q and A with Drs. Mary Pinder-Schenk and Nasser Hanna (audio)
August 17, 2011 22:01 - 35 minutes - 32.5 MBQuestion and answer session with Drs. Mary Pinder-Schenck from Moffitt Cancer Center in Tampa and Nasser Hanna from Indiana University about highlights in lung cancer from ASCO 2011 annual meeting.
ASCO 2011 Highlights: Advanced/Metastatic Non-Small Cell Lung Cancer (audio)
August 02, 2011 21:04 - 23 minutes - 21.6 MBDr. Nasser Hanna from Indiana University Cancer Center reviews highlights of presentations on advanced/metastatic NSCLC from the ASCO 2011 annual meeting.
ASCO 2011 Highlights: SCLC, Early Stage NSCLC and Mesothelioma (audio)
July 19, 2011 03:31 - 40 minutes - 36.8 MBDr. Mary Pinder-Schenck from the H. Lee Moffitt Cancer Center in Tampa, FL reviews highlights of presentations on small cell lung cancer, early stage non-small cell lung cancer, and mesothelioma from the ASCO 2011 meeting.
Challenging Cases in Lung Cancer: Stage IIIA N2 Node-Positive NSCLC (audio)
July 09, 2011 15:00 - 15 minutes - 14.6 MBCase-based discussion with multiple lung cancer experts on the optimal treatment of a patient with multi-station N2 node-positive squamous cell NSCLC, including whether surgery should be pursued.
Challenging Cases in Lung Cancer: Adjuvant Therapy for a Patient with a Smaller Node-Negative NSCLC Tumor (audio)
July 01, 2011 15:00 - 14 minutes - 13.7 MBCase-based discussion with multiple lung cancer experts on whether to recommend post-operative (adjuvant) chemotherapy for a patient with a less than 4 cm non-small cell lung cancer (NSCLC) tumor with some high risk features.
Challenging Cases in Lung Cancer: Adjuvant Therapy for Small NSCLC Lesion with Satellite Nodules (audio)
June 06, 2011 21:17 - 12 minutes - 11.9 MBCase-based discussion with multiple lung cancer experts on whether to recommend post-operative (adjuvant) chemotherapy for a patient with small non-small cell lung cancer (NSCLC) tumor with satellite lesions.
Q and A with Dr. Minesh Mehta on Prevention and Treatment of Brain Metastases in Lung Cancer (audio)
May 04, 2011 07:11 - 29 minutes - 26.8 MBQuestion and answer session with Dr. Minesh Mehta, Professor of Radiation Oncology at Northwestern University, on topics related to treatments for brain metastases and related complications, especially in the setting of lung cancer.
Dr. Minesh Mehta on Prevention and Treatment of Brain Metastases in Lung Cancer (audio)
April 25, 2011 15:00 - 43 minutes - 39.4 MBDr. Minesh Mehta, Professor of Radiation Oncology at Northwestern University, describes benefits and risks of multiple interventions that are currently used or being studied to reduce risk of developing brain metastases or treat established metastases.
Dr. Sequist, Q and A Session following Presentation on Acquired EGFR TKI Resistance and Data from Re-Biopsying Tumors (audio)
April 11, 2011 15:00 - 14 minutes - 13.5 MBDr. Lecia Sequist of Massachusetts General Hospital answers questions about acquired resistance to EGFR tyrosine kinase inhibitors and repeat biopsies of tumors over the course of treatment for advanced NSCLC.
Dr. Lecia Sequist on Results from Re-Biopsying Lung Cancer Lesions Over the Course of Treatment (audio)
April 05, 2011 15:00 - 11 minutes - 10.5 MBDr. Lecia Sequist of Massachusetts General Hospital describes the results of their experience in repeating biopsies in patients over the course of their ongoing treatment for advanced NSCLC and the changes in tumor characteristics over time.
Dr. Lecia Sequist on Acquired Resistance to EGFR Tyrosine Kinase Inhibitors (audio)
March 28, 2011 15:00 - 29 minutes - 26.9 MBDr. Lecia Sequist of Massachusetts General Hospital presents a summary of the challenge of acquired resistance to EGFR tyrosine kinase inhibitors like Tarceva (erlotinib) and Iressa (gefitinib), along with emerging ideas for overcoming it.
Expert Round Table with Drs. Hensing and Jackman on Molecular Markers and Sequencing of Therapy for Advanced NSCLC, Case 3 (audio)
September 09, 2010 12:00 - 16 minutes - 15.3 MBCase discussion with Drs. Tom Hensing of in Chicago & David Jackman in Boston, discussing practical issues around molecular marker testing & recommended treatments for first line & maintenance therapy for a never-smoker with a lung adenocarcinoma.
Expert Round Table with Drs. Hensing and Jackman on Molecular Markers and Sequencing of Therapy for Advanced NSCLC, Case 2 (audio)
August 30, 2010 12:00 - 17 minutes - 24.6 MBCase discussion with Drs. Tom Hensing of in Chicago and David Jackman in Boston, discussing practical issues around molecular marker testing and recommended treatments for first line and maintenance therapy for an ex-smoker with a lung adenocarcinoma.
Expert Round Table with Drs. Hensing and Jackman on Molecular Markers and Sequencing of Therapy for Advanced NSCLC (audio)
August 19, 2010 12:00 - 20 minutes - 18.4 MBCase discussion with Drs. Tom Hensing of in Chicago and David Jackman in Boston, discussing practical issues around molecular marker testing and recommended treatments for first line and maintenance therapy for a patient with advanced squamous cell NSCLC.
Expert Round Table on Bulky Unresectable Stage IIIB NSCLC and the Outer Limits of Curative Intent (audio)
June 11, 2010 12:02 - 16 minutes - 15.5 MBCase discussion with Drs. George Blumenschein of MD Anderson and Walter Curran of Emory University, reviewing concerns about risks of aggressive treatment of bulky locally advanced NSCLC and potential management strategies.
Expert Round Table on Ambiguous Imaging Results and Subsequent Treatment after Chemo/Radiation (audio)
May 25, 2010 12:02 - 15 minutes - 14.4 MBCase discussion with Drs. George Blumenschein of MD Anderson and Walter Curran of Emory University, covering management approaches for a stage IIIB locally advanced NSCLC with ambiguous imaging results after chemo and radiation were completed.
Expert Round Table on Stage IIIA N2 Node-Positive NSCLC: Options for Surgical and Non-Surgical Management (audio)
May 21, 2010 12:02 - 17 minutes - 16.5 MBCase discussion with Drs. George Blumenschein of MD Anderson Cancer Center and Walter Curran of Emory University, reviewing management options for the range of treatment approaches for patients with stage IIIA N2, locally advanced NSCLC.
Expert Round Table on Managing Advanced Non-Small Cell Lung Cancer (NSCLC) in Elderly and Frail Patients (audio)
May 14, 2010 12:02 - 15 minutes - 14.1 MBCase discussion with Drs. Paul Hesketh of the Lahey Clinic and Karen Kelly of Kansas University Medical Center, covering question of optimal treatment for patients with advanced NSCLC who are elderly or have a marginal performance status.
Expert Round Table on Managing Locally Advanced NSCLC in Elderly and Frail Patients (audio)
May 07, 2010 12:02 - 13 minutes - 12.5 MBCase discussion with Drs. Paul Hesketh of the Lahey Clinic and Karen Kelly of Kansas University Medical Center, discussing options for administering multimodality therapy for stage III NSCLC in patients who are elderly or have a marginal performance status.
Expert Round Table on Considerations for Adjuvant Therapy in Elderly and Frail Patients (audio)
May 02, 2010 12:02 - 35 minutes - 32.9 MBCase discussion with Drs. Paul Hesketh of the Lahey Clinic and Karen Kelly of Kansas University Medical Center, discussing current evidence and challenges of post-operative treatments for early stage NSCLC in elderly and/or frail patients.
Q and A Session on Maintenance Therapy for Advanced NSCLC: When, What, Why, and What’s Left After Post-Maintenance Relapse? (audio)
April 18, 2010 12:02 - 15 minutes - 14.6 MBDr. Mark Socinski, medical oncologist and leader of the Thoracic Oncology Program at Univ. of North Carolina, answers questions about what treatments to recommend after first line therapy for advanced NSCLC and when they should be pursued.
Maintenance Therapy for Advanced NSCLC: When, What, Why, and What’s Left After Post-Maintenance Relapse? (audio)
April 07, 2010 12:02 - 36 minutes - 33.7 MBDr. Mark Socinski, medical oncologist and leader of the Thoracic Oncology Program at Univ. of North Carolina, summarizes the evidence and presents a current approach to managing treatment of advanced NSCLC after first line therapy.
Should Surgery be Considered for Very Limited Small Cell Lung Cancer? (audio)
March 31, 2010 12:02 - 24 minutes - 22.3 MBDr. Howard (Jack) West, medical oncologist, President & CEO of GRACE, reviews the debate about whether surgery should have a role in managing early small cell lung cancer (SCLC).
Q and A with Dr. Suresh Ramalingam on Individualizing First Line Therapy for Advanced NSCLC (audio)
March 26, 2010 12:02 - 18 minutes - 16.7 MBDr. Suresh Ramalingam, medical oncologist and leader of the Thoracic Oncology Program at Emory University, discusses questions about individualizing therapy choices for patients with advanced NSCLC.
Individualizing First Line Therapy for Advanced NSCLC, by Dr. Suresh Ramalingam (audio)
March 23, 2010 12:02 - 40 minutes - 37.3 MBDr. Suresh Ramalingam, medical oncologist and leader of the Thoracic Oncology Program at Emory University, reviews the evolution of first line treatment of advanced non-small cell lung cancer to our current tailored approach for optimal outcomes.
The Role of EGFR Inhibitor Therapy as Post-Operative Treatment for Early Stage NSCLC: A Controversial Question (audio)
March 17, 2010 12:02 - 33 minutes - 31 MBDr. Jared Weiss, medical oncologist from the Univ. of Pennsylvania, covers limited data and current clinical trials addressing potential role of EGFR inhibitors, and particularly Tarceva (erlotinib), as post-surgical treatment for advanced NSCLC.
Expert Round Table with Drs. Anne Tsao and Alex Farivar: Case Discussion on Isolated Brain Metastasis (audio)
March 15, 2010 12:02 - 8 minutes - 7.55 MBCase discussion with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute, on a case of man with an isolated brain metastasis being considered for curative therapy.
Case Discussion with Experts, Drs. Julie Brahmer and Greg Riely: Case 1 (audio)
March 08, 2010 13:02 - 21 minutes - 19.9 MBCase discussion with Dr. Julie Brahmer of Johns Hopkins University and Dr. Gregory Riely of Memorial Sloan Kettering, on a case of a woman with poorly differentiated NSCLC, responding well to fist line chemotherapy.
Q and A Session on The Emerging Role of Molecular Markers in NSCLC: a Webinar by Dr. Nathan Pennell (audio)
March 07, 2010 13:02 - 14 minutes - 13.5 MBQ&A Session following webinar with Dr. Nathan Pennell, medical oncologist and lung cancer expert at the Cleveland Clinic Foundation, on the use of molecular markers such as EGFR, KRAS, ERCC-1, EML4-ALK, and others in NSCLC.
Expert Round Table with Drs. Anne Tsao and Alex Farivar: Case Discussion on Malignant Pleural Mesothelioma (audio)
March 04, 2010 13:02 - 17 minutes - 16.3 MBCase discussion with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute, on a case of a relatively fit man with malignant pleural mesothelioma.
ALK gene rearrangements, ALK inhibitors, and the Lung Cancer Revolution, by Dr. D. Ross Camidge (audio)
February 26, 2010 13:02 - 37 minutes - 34.5 MBDr. D. Ross Camidge, medical oncologist at the University of Colorado, provides an overview of the newly identified ALK gene rearrangements, novel therapy to target this, and the promise of molecular oncology.
Expert Round Table with Drs. Anne Tsao and Alex Farivar: Case Discussion on Indolent BornchioloAlveolar Carcinoma (BAC) (audio)
February 22, 2010 13:02 - 17 minutes - 15.8 MBCase discussion of management options for an elderly man with slowly progressing BAC, with Dr. Anne Tsao of medical oncology at MD Anderson, and Dr. Alex Farivar of thoracic surgery at Swedish Cancer Institute.
Interview with Dr. Kristin Manning, Part 1: Screening, Workup, and Follow-Up of Lung Cancer (audio)
February 10, 2010 13:02 - 13 minutes - 12 MBDr. Kristin Manning, expert radiologist at Seattle Radiology, discusses work on lung cancer screening, the features of a pulmonary nodule that raise and lower suspicion for lung cancer, and other aspects of initial and follow-up imaging for lung cancer.